期刊文献+

DNA免疫诱导小鼠产生抗人心肌肌钙蛋白T抗血清的研究

DNA immunization with recombinant expression plasmid of human cardiac troponin T
原文传递
导出
摘要 目的 通过基因免疫诱导BALB c小鼠产生抗人心肌肌钙蛋白T (cTnT)的抗体应答 ,并比较不同免疫佐剂、预处理方法对免疫应答的影响。方法 构建cTnT的真核表达质粒pCI cTnT ,大量提取、PEG纯化质粒 ,通过肌肉注射免疫BALB c小鼠并加强免疫 ,每隔 2周取血 ,ELISA法分析抗cTnT的体液应答 ,免疫印迹检测抗血清的特异性。并比较布吡卡因预处理、CpGODN核酸佐剂、弗氏不完全佐剂对抗体应答效果的影响。结果 接种pCI cTnT质粒的小鼠血清中检测出抗cTnT特异性抗体 ,加强免疫使抗体滴度提高 ;使用CpGODN后免疫应答增强 ,弗氏不完全佐剂可明显增强免疫效果 ,而吡卡因预处理使应答水平下降 ;初次免疫后 14周仍可测得较高的抗体应答。结论 采用含cTnT基因的质粒DNA免疫 ,成功地诱导小鼠产生抗cTnT的抗体 ;传统的弗氏不完全佐剂可作为核酸免疫的佐剂使用。 Objective To induce an antibody response to human cardiac troponin T (cTnT) by intramuscular immunization with recombined expression plasmid DNA for cTnT and to compare the efficacy of different adjuvants. Methods cDNA of cTnT gene was cloned into mammalian expression vector and the expression plasmids were purified by PEG method. Specific antibodies in sera were analyzed by ELISA and Western blot after the cTnT expression plasmids were intramuscularly injected into mice. The efficacy of different adjuvant/pretreatment methods: CpG-ODN, pretreatment with bupivacaine, incomplete Freund's adjuvant (IFA), on the immunogenicity of DNA vaccines were also assessed. Results Specific antibody to cTnT was induced by DNA-mediated immunization. The immunogenicity of pCI-cTnT vector was increased by using CpG-ODN while reduced by bupivacaine pretreatment method. IFA has a significant effect on antibody responses of gene immunization. Conclusion Specific antibody response to human cTnT was successfully induced by DNA immunization IFA can be used as an adjuvant in DNA immunization.
作者 葛新 李强
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2003年第7期544-547,共4页 Chinese Journal of Microbiology and Immunology
基金 清华大学生命科学 985资助项目
关键词 心肌肌钙蛋白T 核酸免疫 CpG-ODN核酸佐剂 弗氏不完全佐剂 布吡卡因预处理 心血管疾病 DNA immunization Troponin T CpG oligodeoxynucleotide (CpG ODN) Incomplete Freund′s adjuvant
  • 相关文献

参考文献10

  • 1Galvani M, Ferrini D, Puggioni R, et al. New markers for early diagnosis of acute myocardial infarction. International Journal of Cardiology, 1998,65: S17-S22.
  • 2Yu H, Zhao W, Fan HA, et al. Evaluation of serum troponin T measurement infraction. Chinese Medical Journal, 1995, 106: 501-506.
  • 3Setsuta K, Seino Y, Takahashi N, et al. Clinical significance of elevated levels of cardiac troponin T in patients with chronic heart failure. The American Journal of Cardiology, 1999, 84: 608-611.
  • 4Mach F, Lovis C, Chevrolet JC, et al. Rapid bedside whole blood cardiospecific troponin T immunoassay for the diagnosis of acute mayocardial infarction. The American Journal of Cardiology, 1995, 75: 842-845.
  • 5Krieg A, Yi A, Matson S, et al. CpG motifs in bacterial DNA triggex direct B-cell activation. Nature, 1995, 374: 546-549.
  • 6Jin JP, Lin JJ. Rapid purification of mammalian cardiac troponin T and its isoform switching in rat hearts during development. Journal of Biological Chemistry, 1989, 263: 7309-7315.
  • 7Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual 2nd Ed, New York: Cold Spring Harbor Laboratory Press,1989.
  • 8Endresz V, Burian K, Berencsi K, et al. Optimization of DNA immunization against human cytomegalovirus. Vaccine, 2001, 19: 3972-3980.
  • 9McNeela E, Mills K. Manipulating the immune system: humoral versus cell-mediated immunity . Advanced Drug Delivery Review, 2001, 51: 43-54.
  • 10Wang B, Mgen KE, Srikantan V, et al. Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc Natl Acad Sci USA, 1993, 90: 4146-4160.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部